HB 7 authorizes Maryland's State Board of Examiners to issue limited licenses for music therapists who are completing full licensing requirements but lack sufficient clinical experience. This directly affects new music therapists and healthcare facilities needing to hire them under supervision while they fulfill certification steps. The bill creates a 1-year limited license (renewable once) requiring direct supervision by a fully licensed music therapist, with a 2-year deadline to obtain full licensure. It explicitly states limited licenses cannot replace services from audiologists or speech-language pathologists. The policy change streamlines entry into the profession without altering existing practice standards for music therapy.
HB 393 requires health insurers, nonprofit health plans, HMOs, and managed care organizations in Maryland to cover scalp cooling systems when they provide coverage for chemotherapy treatments for cancer. This applies directly to cancer patients undergoing chemotherapy who use scalp cooling to prevent hair loss, and to the insurers that must now include this coverage. The bill defines scalp cooling systems as medical devices designed for repeated use to preserve hair during cancer treatment. Coverage must be provided for these systems as part of chemotherapy treatment plans, effective January 1, 2027. The law amends Maryland’s Insurance Article (Section 15-864) to mandate this coverage for qualifying health plans.
HB 442 requires nursing homes, assisted living facilities, and nurse midwives in Maryland to disclose their professional liability insurance status to residents and potential residents. Specifically, these providers must provide written notice (including electronic communication) if they lack coverage or if coverage has lapsed and not been renewed, with timing requirements: at the first visit for potential residents or at application for admission, and within 30 days of a lapse for current residents. The bill also mandates that facilities without coverage post a conspicuous notice for residents and guests. This law does not change insurance requirements but ensures transparency about coverage gaps. It directly affects residents and potential residents of these care facilities by providing clear, timely disclosure of insurance status.
HB 813 authorizes Maryland's Medicaid program (Maryland Medical Assistance Program) to cover comprehensive obesity treatment, including intensive behavioral therapy, bariatric surgery, and FDA-approved weight management medications, starting January 1, 2027. The bill requires the Maryland Department of Health to notify Medicaid recipients if it chooses to provide this coverage and mandates a report to the legislature by November 1, 2027, on implementation progress. This directly affects Medicaid recipients with obesity by expanding covered treatments beyond current scope. The program may use standard utilization management processes (like for other conditions) to assess medical necessity but is not required to offer the coverage.
HB 373 allows Maryland's State Board of Dental Examiners to conduct unannounced inspections of non-hospital dental offices to verify compliance with CDC infection control guidelines. It updates disciplinary rules for dentists, dental hygienists, and dental assistants by adding failure to follow these guidelines as grounds for license denial, suspension, or revocation. The bill also requires certified expanded function dental assistants to be properly trained and supervised, and prohibits employers from using uncertified assistants or violating specific practice standards. These changes directly affect dental professionals and their practices across Maryland.
This bill requires Maryland colleges and universities to provide reasonable accommodations to students with sickle cell disease and prohibits denying them access to facilities or services based on their diagnosis. It mandates the Maryland Department of Health to create an education campaign for campus staff, develop guidelines for supporting students with sickle cell disease, and compile training materials for faculty and administrators. The law directly affects students with sickle cell disease at public and private institutions of higher education in Maryland, as well as campus staff responsible for implementing these policies. The requirements take effect October 1, 2026, with institutions needing to establish clear reporting procedures for violations.
